The Efficacy of Teneligliptin with Metformin in Drug-Naive Type 2 Subjects

被引：2
|
作者：
Chudasama, Dipak B.
Saboo, Banshi D.
Panchal, Dharmendra
Patel, Feny
Saiyed, Mahira
Hasnani, Dhruvi
Chavda, Vipul
Chandarana, Hardik
Goklani, Rutul
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1205-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    DIABETOLOGIA, 2006, 49 : 479 - 480
  • [2] Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes
    Stenlof, K.
    Rossner, S.
    Vercruysse, F.
    Kumar, A.
    Fitchet, M.
    Sjostrom, L.
    DIABETES OBESITY & METABOLISM, 2007, 9 (03): : 360 - 368
  • [3] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A346 - A346
  • [4] Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes
    Pi-Sunyer, F. Xavier
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 132 - 138
  • [5] Epigenetic markers associated with metformin response and intolerance in drug-naive patients with type 2 diabetes
    Garcia-Calzon, Sonia
    Perfilyev, Alexander
    Martinell, Mats
    Ustinova, Monta
    Kalamajski, Sebastian
    Franks, Paul W.
    Bacos, Karl
    Elbere, Ilze
    Pihlajamaki, Jussi
    Volkov, Petr
    Vaag, Allan
    Groop, Leif
    Maziarz, Rlena
    Klovins, Janis
    Ahlqvist, Emma
    Ling, Charlotte
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (561)
  • [6] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    DIABETOLOGIA, 2015, 58 : S54 - S54
  • [7] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
  • [8] Combinations of empagliflozin/linagliptin for 24 weeks in drug-naive subjects with Type 2 diabetes
    Lewin, A.
    DeFronzo, R. A.
    Patel, S.
    Liu, D.
    Kaste, R.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 90 - 90
  • [9] Effect of topiramate on body composition in obese, drug-naive, type 2 diabetic subjects
    Lonn, L
    Sjostrom, L
    Stenlof, K
    Vercruysse, F
    Perry, B
    Fitchet, M
    OBESITY RESEARCH, 2003, 11 : A109 - A109
  • [10] The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A455 - A455
12345